$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Inhibition of Prolyl 4-Hydroxylase by Oxaproline Tetrapeptides In Vitro and Mass Analysis for the Enzymatic Reaction Products

Abstract

A series of 5-oxaproline peptide derivatives was synthesized and evaluated for its ability to inhibit the prolyl 4-hydroxylase in vitro. Structure-activity studies show that the 5-oxaproline sequences, prepared by the 1,3-dipolar cycloaddition of the C-methoxycarbonyl-N-mannosyl nitrone in the presence of the ethylene, are more active than the corresponding proline derivatives. Prolyl 4-hydroxylase belongs to a family of $Fe^{2+}-dependent$ dioxygenase, which catalyzes the formation of 4-hydroxyproline in collagens by the hydroxylation of proline residues in -Gly-Xaa-Pro-Gly- of procollagen chains. In this paper we discover the more selective N-Cbz-Gly-Phe-Pro-Gly-OEt $(K_m\;=\;520\;{\mu}M)$ sequences which are showed stronger binding than others in vitro. Therefore, we set out to investigate constrained tetrapeptide that was designed to mimic the proline structure of pep tides for the development of prolyl 4-hydroxylase inhibitor. From this result, we found that the most potent inhibitor is N-Dansyl-Gly-Phe-5-oxaPro-Gly-OEt $(K_i\;=\;1.6\;{\mu}M)$. This has prompted attempts to develop drugs which inhibit collagen synthesis. Prolyl 4-hydroxylase would seem a particularly suitable target for antifibrotic therapy.

참고문헌 (11)

  1. Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system. , Vuori, K., T. Pihlajaniemi, M. Marttila, and K. I. Kivirikko , Proc. Natl. Acad. Sci. U.S.A. / v.89,pp.7467-7470, 1992
  2. Mechanism-based inactivation of the human prolyl 4-hydroxylase by 5-oxaproline-containing peptides: Evidence for a prolyl radical intermediate. , Wu, M., H. S. Moon, T. P. Begley, J. Myllyharju, and K. I. Kivirikko , J. Am. Chem. Soc. / v.121,pp.587-588, 1999
  3. A stereochemical concept for the catalytic mechanism of prolyl hydroxylase. Applicability to classification and design of inhibitors. , Hanauske-Abel, H. M. and V. A. Gunzler , J. Theor. Biol. / v.94,pp.421-455, 1982
  4. Crystal and molecular structure of a collagen-like peptide at 1.9 Aresolution. , Bella, J. M. Eaton, B. Brodsky, and H. M. Berman , Science / v.266,pp.75-81, 1994
  5. Collagens and their abnormalities in a wide spectrum of diseases. , Kivirikko, K. I. , Annals Med. / v.25,pp.113-126, 1993
  6. Novel inhibitors of prolyl 4-hydroxylase. , Cunliffe, C. J., T. J. Franklin, N. J. Hales, and G. B. Hill , J. Med. Chem. / v.35,pp.2652-2658, 1992
  7. Syncatalytic inactivation of prolyl 4-hydroxylase by anthracyclines. , Gunzler, V., H. M. Hanauske-Abel, R. Myllyla, D. Kaska, A. Hanauske, and K. I. Kivirikko , Biochem. J. / v.251,pp.365-372, 1988
  8. Syncatalytic inactivation of prolyl 4-hydroxylase by synthetic peptides containing the unphysiologic amino acid 5-oxaproline. , Gunzler, V., D. Brocks, S. Henke, R. Myllyla, R. Geoiger, and K. I. Kivirikko , J. Biol. Chem. / v.263,pp.19498-19504, 1988
  9. Eds. In collagen in health and disease; Churchill livingstone: Edinburgh 160-178; Dowell, R. I., and E. M. Hadley (1992) Novel inhibitors of prolyl 4-hydroxylase. , Weiss, J. B. and M. I. V. Jayson , J. Med. Chem. / v.35,pp.800-804, 1982
  10. Synthesis of 2,4,5-triphenyl-substituted oxazolidine and 2,5-diphenylsubstituted pyrrolidine derivatives. , Wittland, C., M. Arend, and N. Risch , Synthesis / v.3,pp.367-371, 1996
  11. Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. , Kivirikko, K. I., R. Myllyala, and T. Pihlajaniemi , FASEB J. / v.3,pp.1607-1617, 1989

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일